Scot Garg - Concepedia

Author

Scot Garg

Also Known As

A Nilsson, A Shantsila, Garg, S., Garg, Shweta, Héctor M. García-García, Jan Piek, M. Kutlu, R Singh, R. Singh, Raimund Erbel

432

Publications

15.9K

Citations

H-Index

100

Concepts

All Affiliations

Erasmus University Rotterdam Royal Blackburn Teaching Hospital Ollscoil na Gaillimhe – University of Galway Erasmus MC Imperial College London

About

Scot Garg is an author at Erasmus University Rotterdam specializing in medicine, cardiovascular disease, and coronary heart disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	52	3.6K
2	Engineering	8	8	501
3	Language Studies	3	3	98
4	Health Sciences	2	2	95
5	Management	2	2	231

Scot Garg

139

Publications

8.4K

Citations

H-Index

Page 1

	Year	Citations
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial Pascal Vranckx, Marco Valgimigli, Peter Jüni, The Lancet Endovascular TechniqueCardiovascular DiseaseRandomised Superiority TrialLumen-apposing Metal StentPharmacotherapy	2018	761
Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents Patrick W. Serruys, Sigmund Silber, Scot Garg, New England Journal of Medicine	2010	656
Assessment of the SYNTAX score in the Syntax study Patrick Serruys, Yoshinobu Onuma, Scot Garg, EuroIntervention	2009	635
Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention: a patient-level pooled analysis of 7 contemporary stent trials Christos V. Bourantas, Yao‐Jun Zhang, Scot Garg, Heart	2014	328
A New Tool for the Risk Stratification of Patients With Complex Coronary Artery Disease Scot Garg, Giovanna Sarno, Héctor M. García‐García, Circulation Cardiovascular Interventions	2010	255
5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions Patrick W. Serruys, Yoshinobu Onuma, Scot Garg, Journal of the American College of Cardiology Arts IiPercutaneous Coronary InterventionSirolimus-eluting StentEndovascular TechniqueCardiovascular Disease	2010	241
Value of the SYNTAX Score for Risk Assessment in the All-Comers Population of the Randomized Multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Trial Joanna J. Wykrzykowska, Scot Garg, Chrysafios Girasis, Journal of the American College of Cardiology ReliabilityRisk AssessmentLimus ElutedEngineeringDisease Risk Assessment	2010	218
SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial Chrysafios Girasis, Scot Garg, Lorenz Räber, European Heart Journal	2011	157
Prediction of 1-Year Clinical Outcomes Using the SYNTAX Score in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Scot Garg, Giovanna Sarno, Patrick W. Serruys, JACC: Cardiovascular Interventions Percutaneous Coronary Intervention1-Year Clinical OutcomesCardiovascular DiseaseCoronary UnitPatient Safety	2011	155
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting Anna Franzone, Eugène McFadden, Sergio Leonardi, Journal of the American College of Cardiology Percutaneous Coronary InterventionThrombosisCardiovascular DiseasePharmacologyCardiology	2019	145

Page 1